|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
11/4/2008 10:06:19 AM
SCHAUMBURG, Ill.--(BUSINESS WIRE)--Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ) (“FKP Holdings”) the newly formed holding company that acquired APP Pharmaceuticals, Inc. (“APP”) on September 10, 2008, today released financial results for the third quarter and for the nine months ended September 30, 2008. These results include APP’s results for the portion of the third quarter and the nine-month period prior to the closing of the acquisition and FKP Holdings’ results from July 2, 2008, through September 30, 2008, which also includes the results of operations of APP post acquisition.
|
|
|
|
|
|
|
|
|
|
|